Fidus Investment Corp. 10-Q Summary: Quarter Ended March 31, 2016
Business Context and Reporting Period
Fidus Investment Corporation (Fidus) is a Maryland corporation operating as a Business Development Company (BDC) and a Regulated Investment Company (RIC). It provides customized debt and equity financing to lower middle-market U.S. companies. The company operates through two wholly-owned Small Business Investment Company (SBIC) subsidiaries, Fund I and Fund II. This report covers the quarterly period ended March 31, 2016.
Key Financial Metrics
| Metric | Q1 2016 | Q1 2015 |
|---|---|---|
| Total Investment Income | $14.69 million | $12.84 million |
| Net Investment Income | $7.08 million | $6.23 million |
| Net Increase in Net Assets from Operations | $7.54 million | $6.41 million |
| Net Asset Value (NAV) per Share | $15.25 | $15.18 |
| Dividends Declared per Share | $0.39 | $0.38 |
| Total Investments (Fair Value) | $455.68 million | $443.27 million |
| Cash and Cash Equivalents | $13.04 million | $31.66 million |
| Total Debt (SBA Debentures + Credit Facility) | $220.39 million (net of deferred costs) | $224.13 million (net of deferred costs) |
| Weighted Average Yield on Debt | 13.3% | 13.3% |
Material Changes vs. Prior Period
- Revenue Growth: Total investment income increased by 14.4% ($1.85 million) compared to Q1 2015, driven primarily by a $1.52 million increase in interest income due to higher average debt investment levels.
- Expense Increase: Total expenses rose 15.1% to $7.58 million. Interest and financing expenses increased 22.1% due to higher average balances of SBA debentures and credit facility borrowings. The incentive fee increased 17.6% to $1.88 million.
- Portfolio Activity: The company invested $42.35 million in new debt and equity (including three new portfolio companies) and received $31.58 million in proceeds from sales and repayments.
- Cash Position: Cash and cash equivalents decreased significantly from $31.66 million to $13.04 million, reflecting net cash used in operating activities ($8.43 million) and financing activities ($10.19 million).
- Realized Losses: The company recorded a net realized loss of $0.31 million, primarily due to the exit of Continental Anesthesia Management, LLC. This contrasts with no realized gains or losses in Q1 2015.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes current cash resources, access to SBA-guaranteed debentures, and the Credit Facility provide adequate capital for at least the next 12 months. Fund II has approximately $11.0 million of remaining borrowing capacity under the SBIC program.
- Dividends: A regular quarterly dividend of $0.39 per share was declared on May 2, 2016, payable June 24, 2016.
- Asset Quality: As of March 31, 2016, one portfolio company debt investment was on non-accrual status with a fair value of $0 (cost $5.2 million). The weighted average portfolio rating was 2.1 (on a 1-5 scale), indicating generally stable performance.
- Stock Repurchase: The company has a $5.0 million open market repurchase program but did not repurchase any shares during the quarter.
- Risks: Key risks include economic downturns affecting portfolio companies, credit contraction, interest rate volatility, and the inherent uncertainty in valuing illiquid private investments.
Investor Verification Checklist
- Non-Accrual Status: Verify the specific details and recovery prospects of the single portfolio company on non-accrual status (Paramount Building Solutions, LLC), which has a fair value of $0.
- Debt Maturity Profile: Review the maturity schedule of SBA debentures and the Credit Facility to assess refinancing risks and interest rate exposure.
- Valuation Methodology: Confirm the Board's "good faith" valuation process for Level 3 assets, particularly given the significant unrealized appreciation in equity investments offsetting debt depreciation.
- Capital Deployment: Monitor the utilization of the remaining $11.0 million SBA debenture capacity and the $50.0 million Credit Facility commitment.
- Dividend Coverage: Assess the sustainability of the $0.39 quarterly dividend given the mix of cash and paid-in-kind (PIK) income in the portfolio.